This page lists the SEC filings reported by Shin Nippon Biomedical Laboratories, Ltd..
| Type | Filed | Filer | Subject | Shares Owned | Percent Owned | |
|---|---|---|---|---|---|---|
| SC 13D/A | 2023-06-08 | Shin Nippon Biomedical Laboratories, Ltd. | Satsuma Pharmaceuticals, Inc. | 1,000 | 100.0% | EDGAR |
| SC 13D/A | 2023-04-17 | Shin Nippon Biomedical Laboratories, Ltd. | Satsuma Pharmaceuticals, Inc. | 2,794,113 | 8.4% | EDGAR |
| SC 13D/A | 2022-08-12 | Shin Nippon Biomedical Laboratories, Ltd. | Wave Life Sciences Ltd. | 9,606,408 | 10.6% | EDGAR |
| SC 13D | 2021-03-31 | Shin Nippon Biomedical Laboratories, Ltd. | Satsuma Pharmaceuticals, Inc. | 2,794,113 | 8.9% | EDGAR |
| SC 13D/A | 2019-02-20 | Shin Nippon Biomedical Laboratories, Ltd. | Wave Life Sciences Ltd. | 5,885,478 | 17.6% | EDGAR |
| SC 13D/A | 2018-04-26 | Shin Nippon Biomedical Laboratories, Ltd. | Wave Life Sciences Ltd. | 5,885,478 | 21.0% | EDGAR |
| SC 13D/A | 2016-09-29 | Shin Nippon Biomedical Laboratories, Ltd. | Wave Life Sciences Ltd. | 5,885,478 | 21.5% | EDGAR |
| SC 13D/A | 2016-07-26 | Shin Nippon Biomedical Laboratories, Ltd. | Wave Life Sciences Ltd. | 5,885,478 | 21.5% | EDGAR |
| SC 13D | 2015-11-25 | Shin Nippon Biomedical Laboratories, Ltd. | Wave Life Sciences Ltd. | 5,885,478 | 23.7% | EDGAR |
- Form 13F-HR
- The 13F-HR report is filed quarterly to report securities held by the filer that fall under the SEC's 13F rules.
- Form SC 13D/G
- Reported by persons and groups who own 5% or more of any class of a company's outstanding shares. If the ownership changes by 1% or more, an amendment must be filed.
- Form 3, 4, and 5
- Form 3, 4, and 5 reports are filed to report insider transactions by company officers and directors, and any beneficial owners of more than ten percent of a company's shares. Form 3 is the initial report that must be filed when a person becomes an officer, director, or beneficial owner. Form 4 reports are used to report changes in ownership, while the Form 5 report is used for reporting transactions that should have been reported earlier in a Form 4 filing.